stage 3 lymphoma | Life expectancy of a patient stage 3 Lymph Node cancer

Life expectancy of a patient stage 3 Lymph Node cancer



Life expectancy of a patient stage 3 Lymph Node cancer
The lymphatic system includes a network of vessels that carry fluid, lymph through the body. Lymph contains lymphocytes, or white blood cells, cells of the immune system fighting the disease. Lymph nodes filter lymph and can become cancerous. There are about 35 types of lymphocytes which may be involved in lymph nodes (Lymphoma) cancers. According to the Emedicinehealth site, lymphoma is the most common type of blood cancer in the United States.

Types
Lymphoma prognosis varies depending on the type, age at diagnosis, and previous health problems. Lymphoma can be hodgkiniens or not hodgkiniens and it can be indolent or aggressive. The difference between Hodgkin's disease and Lymphoma non hodgkiniens of lymphocytes is specific to the (white blood cells) that it affects. The presence of a Reed-Sternberg cell, a specific type of white blood cells anomaly, indicates the Hodgkin's lymphoma. If the Reed-Sternberg cell is absent, the lymphoma is the variety of the non-Hodgkin's disease, according to the Mayo Clinic. Indolent lymphoma is of low quality, which means it's slow and easy to deal with. Aggressive lymphoma spreads quickly and can progress quickly from step 1 to step 4. Determine your variety of lymphoma is the first step in determining your expected life expectancy.

Stage 3 Lymphoma
Stage 3 lymphoma is the last stage of the disease, when he reached the internal organs, bone marrow and blood. On average, more the stage of lymphoma, better are the chances of survival. Stage 3 Lymphoma patients who have no other symptoms (such as fever, night sweats and weight loss) have a better prognosis than those who, according to the website info lymphoma.

Prognosis tools
According to the American Cancer Society, there are several factors to consider during a prognosis of life expectancy. In addition to the phase of the disease, other important factors include: age; If the cancer is outside the system of lymphatic organs; how a person can perform daily activities; and blood serum of lactate dehydrogenase (LDH) levels, which increase quickly when tumors are growing fast. Based on these criteria, the doctors to assess the survival rate for each risk group: low, intermediate and high.

State 3 non Hodgkin Lymphoma
The survival rate at five years for patients with non-Hodgkin Lymphoma in the high-risk category is 53 percent, according to the American Cancer Society. The survival rate for ten years for this group is 36 percent. The average five-year survival rate is 63 percent. The average ten-year survival rate is 51 per cent.

Stage 3 Hodgkin's lymphoma
Hodgkin's lymphoma is the rarer of the two forms. The average five-year survival rate is 85 percent, while the average 10-year survival rate is 81 percent. As develop therapies, life expectancy becomes longer. It was a significant improvement in results since the 1970s. Today 92 percent of patients with Hodgkin's lymphoma survive for at least one year after diagnosis.